InsiderTrades.com logo

NTLA Insider Trading

Insider Ownership Percentage: 3.10%
Insider Buying (Last 12 Months): $1,003,000.00
Insider Selling (Last 12 Months): $677,745.91

Intellia Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Intellia Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intellia Therapeutics Share Price & Price History

Current Price: $12.49
Price Change: ▲ Price Increase of +0.21 (1.71%)
As of 02/9/2026 05:00 PM ET

This chart shows the closing price history over time for NTLA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Intellia Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2026Birgit C SchultesEVPSell8,508$9.21$78,358.6898,533View SEC Filing Icon  
1/5/2026James BastaEVPSell10,397$9.21$95,756.37101,528View SEC Filing Icon  
1/5/2026John M LeonardCEOSell34,146$9.21$314,484.661,013,339View SEC Filing Icon  
10/1/2025Birgit C SchultesEVPSell31$17.38$538.78105,184View SEC Filing Icon  
10/1/2025Michael P DubeCAOSell1,871$17.38$32,517.9855,266View SEC Filing Icon  
8/20/2025William J. ChaseDirectorBuy100,000$10.03$1,003,000.00134,693View SEC Filing Icon  
7/23/2025J Dulac IIIEVPSell7,462$14.02$104,617.24106,062View SEC Filing Icon  
7/2/2025Michael P DubeCAOSell2,503$9.95$24,904.8557,137View SEC Filing Icon  
7/1/2025Eliana ClarkEVPSell1,022$9.82$10,036.0495,369View SEC Filing Icon  
7/1/2025Jesse GoodmanDirectorSell1,547$9.23$14,278.8124,359View SEC Filing Icon  
4/29/2025Muna BhanjiDirectorSell265$8.50$2,252.5019,203View SEC Filing Icon  
1/29/2025Muna BhanjiDirectorSell265$9.97$2,642.0519,468View SEC Filing Icon  
1/3/2025John M LeonardCEOSell26,807$12.18$326,509.26941,115View SEC Filing Icon  
1/3/2025Michael P DubeCAOSell1,372$12.18$16,710.9645,640View SEC Filing Icon  
1/2/2025Eliana ClarkEVPSell556$12.03$6,688.6871,470View SEC Filing Icon  
10/2/2024Michael P DubeCAOSell2,012$19.01$38,248.1247,012View SEC Filing Icon  
7/1/2024Eliana ClarkEVPSell405$22.93$9,286.6571,470View SEC Filing Icon  
3/4/2024James BastaEVPSell2,297$32.99$75,778.0381,571View SEC Filing Icon  
1/8/2024Laura Sepp-LorenzinoEVPSell2,275$28.87$65,679.2543,927View SEC Filing Icon  
1/3/2024David LebwohlEVPSell5,843$29.46$172,134.7854,372View SEC Filing Icon  
1/3/2024Glenn GoddardCFOSell5,365$29.46$158,052.9040,585View SEC Filing Icon  
1/3/2024John M LeonardCEOSell19,223$29.46$566,309.58846,486View SEC Filing Icon  
10/31/2023Muna BhanjiDirectorSell265$23.90$6,333.5011,996View SEC Filing Icon  
7/31/2023Muna BhanjiDirectorSell265$42.33$11,217.4512,261View SEC Filing Icon  
7/6/2023Muna BhanjiDirectorSell1,867$39.30$73,373.1012,526View SEC Filing Icon  
7/3/2023Eliana ClarkEVPSell360$40.51$14,583.6045,146View SEC Filing Icon  
6/20/2023Eliana ClarkEVPSell5,000$45.00$225,000.0045,146View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Intellia Therapeutics (NASDAQ:NTLA)

88.77% of Intellia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NTLA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Intellia Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/9/2026Geode Capital Management LLC2,696,187$24.24M0.0%+4.1%2.328%Search for SEC Filing on Google Icon
2/6/2026Axxcess Wealth Management LLC21,399$0.19M0.0%+20.1%0.018%Search for SEC Filing on Google Icon
2/6/2026Nano Cap New Millennium Growth Fund L P12,500$0.11M0.1%N/A0.011%Search for SEC Filing on Google Icon
2/6/2026Leonteq Securities AG56,790$0.51M0.0%N/A0.049%Search for SEC Filing on Google Icon
2/6/2026GSA Capital Partners LLP233,080$2.10M0.2%+210.4%0.201%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB33,800$0.30M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/6/2026Profund Advisors LLC79,664$0.72M0.0%+101.2%0.069%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC23,914$0.22M0.0%+15.0%0.021%Search for SEC Filing on Google Icon
2/5/2026Pinnacle Associates Ltd.149,231$1.34M0.0%-8.8%0.129%Search for SEC Filing on Google Icon
2/4/2026VIRGINIA RETIREMENT SYSTEMS ET Al21,342$0.19M0.0%+27.5%0.018%Search for SEC Filing on Google Icon
2/4/2026Nwam LLC19,540$0.18M0.0%+86.1%0.017%Search for SEC Filing on Google Icon
2/3/2026Ballentine Partners LLC16,011$0.14M0.0%-6.5%0.014%Search for SEC Filing on Google Icon
2/3/2026Wesbanco Bank Inc.64,000$0.58M0.0%N/A0.055%Search for SEC Filing on Google Icon
2/3/2026Canal Insurance CO100,000$0.90M0.2%N/A0.086%Search for SEC Filing on Google Icon
2/3/2026Mitsubishi UFJ Asset Management Co. Ltd.31,085$0.29M0.0%+14.5%0.027%Search for SEC Filing on Google Icon
2/2/2026Benjamin Edwards Inc.79,200$0.71M0.0%+22.1%0.068%Search for SEC Filing on Google Icon
2/2/2026LMG Wealth Partners LLC11,918$0.11M0.0%-15.8%0.010%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer & Co. Inc.105,165$0.95M0.0%+0.8%0.091%Search for SEC Filing on Google Icon
1/30/2026Wealthfront Advisers LLC13,432$0.12M0.0%N/A0.012%Search for SEC Filing on Google Icon
1/29/2026Comerica Bank2,869$26K0.0%+45.8%0.002%Search for SEC Filing on Google Icon
1/29/2026D.A. Davidson & CO.84,000$0.76M0.0%+30.8%0.073%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA11,504$0.10M0.0%N/A0.010%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.13,010,001$116.96M0.0%+17.8%11.232%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.18,874$0.17M0.0%-51.4%0.016%Search for SEC Filing on Google Icon
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH98,597$0.89M0.0%-13.1%0.085%Search for SEC Filing on Google Icon
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank 63,178$0.57M0.0%+17.9%0.055%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.5,629$51K0.0%+35.6%0.005%Search for SEC Filing on Google Icon
1/26/2026CWM LLC22,890$0.21M0.0%+19.3%0.020%Search for SEC Filing on Google Icon
1/26/2026Generali Investments Towarzystwo Funduszy Inwestycyjnych40,000$0.36M0.2%-50.0%0.035%Search for SEC Filing on Google Icon
1/23/2026Sumitomo Mitsui Trust Group Inc.2,192,461$19.71M0.0%-6.9%1.893%Search for SEC Filing on Google Icon
1/22/2026Massachusetts Financial Services Co. MA35,398$0.32M0.0%N/A0.031%Search for SEC Filing on Google Icon
1/21/2026Newbridge Financial Services Group Inc.9,425$85K0.0%+46.1%0.008%Search for SEC Filing on Google Icon
1/20/2026SteelPeak Wealth LLC21,006$0.19M0.0%N/A0.018%Search for SEC Filing on Google Icon
1/15/2026Nisa Investment Advisors LLC31,735$0.29M0.0%+2,193.0%0.027%Search for SEC Filing on Google Icon
1/15/2026Lewis Asset Management LLC14,270$0.13M0.1%-41.9%0.012%Search for SEC Filing on Google Icon
1/15/2026Allspring Global Investments Holdings LLC17,250$0.16M0.0%+8.4%0.015%Search for SEC Filing on Google Icon
1/14/2026Hennion & Walsh Asset Management Inc.166,721$1.50M0.1%+10.9%0.144%Search for SEC Filing on Google Icon
1/14/2026Spire Wealth Management4,065$37K0.0%N/A0.004%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC73,143$0.66M0.0%-44.2%0.063%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC10,345$0.10M0.0%N/A0.009%Search for SEC Filing on Google Icon
1/7/2026Green Alpha Advisors LLC16,693$0.15M0.1%N/A0.014%Search for SEC Filing on Google Icon
1/7/2026Cyndeo Wealth Partners LLC25,280$0.23M0.0%+115.9%0.022%Search for SEC Filing on Google Icon
12/15/2025Hudson Bay Capital Management LP230,000$3.97M0.0%-50.5%0.199%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.10,585$0.18M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/19/2025Danske Bank A S2,900$50K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/19/2025Caitong International Asset Management Co. Ltd1,749$30K0.0%N/A0.002%Search for SEC Filing on Google Icon
11/18/2025Advisory Services Network LLC1,889$33K0.0%N/A0.002%Search for SEC Filing on Google Icon
11/17/2025Kestra Private Wealth Services LLC35,208$0.61M0.0%N/A0.030%Search for SEC Filing on Google Icon
11/17/2025Armistice Capital LLC672,000$11.61M0.2%+3.4%0.580%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co25,027$0.42M0.0%+15.1%0.022%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP200,998$3.47M0.0%-83.5%0.174%Search for SEC Filing on Google Icon
11/17/2025PDT Partners LLC156,804$2.71M0.2%-20.2%0.135%Search for SEC Filing on Google Icon
11/17/2025Dark Forest Capital Management LP10,558$0.18M0.0%-71.1%0.009%Search for SEC Filing on Google Icon
11/17/2025Voloridge Investment Management LLC1,610,205$27.81M0.1%+3.7%1.390%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC32,297$0.56M0.0%-70.3%0.028%Search for SEC Filing on Google Icon
11/17/2025Steadfast Capital Management LP365,400$6.31M0.1%N/A0.315%Search for SEC Filing on Google Icon
11/17/2025Scientech Research LLC28,087$0.49M0.2%N/A0.024%Search for SEC Filing on Google Icon
11/17/2025Sherbrooke Park Advisers LLC20,898$0.36M0.2%+14.3%0.018%Search for SEC Filing on Google Icon
11/17/2025Northwestern Mutual Wealth Management Co.7,080$0.12M0.0%+38.6%0.006%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC607,563$10.49M0.0%-26.9%0.525%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.120,415$2.08M0.0%-7.0%0.104%Search for SEC Filing on Google Icon
11/17/2025Granahan Investment Management LLC342,586$5.92M0.2%-62.5%0.296%Search for SEC Filing on Google Icon
11/17/2025Farallon Capital Management LLC607,200$10.49M0.0%N/A0.524%Search for SEC Filing on Google Icon
11/17/2025Fred Alger Management LLC51,790$0.89M0.0%N/A0.045%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP64,154$1.11M0.0%+190.3%0.055%Search for SEC Filing on Google Icon
11/17/2025Baker BROS. Advisors LP2,746,674$47.44M0.3%+2.7%2.371%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE605,526$10.46M0.0%+41.1%0.523%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.49,647$0.86M0.0%+320.6%0.043%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC18,447$0.32M0.0%N/A0.016%Search for SEC Filing on Google Icon
11/14/2025Creative Planning35,733$0.62M0.0%+7.9%0.031%Search for SEC Filing on Google Icon
11/14/2025Lazard Asset Management LLC114,614$1.98M0.0%+24.0%0.099%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.316,950$5.47M0.0%+6.1%0.274%Search for SEC Filing on Google Icon
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 53,603$0.93M0.0%+51.7%0.046%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC241,282$4.17M0.0%-62.2%0.208%Search for SEC Filing on Google Icon
11/14/2025Tower Research Capital LLC TRC 63,509$1.10M0.0%+20.1%0.055%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP2,449,607$42.31M0.1%+7.6%2.115%Search for SEC Filing on Google Icon
11/13/2025Jump Financial LLC275,992$4.77M0.0%-39.6%0.238%Search for SEC Filing on Google Icon
11/13/2025Kennedy Capital Management LLC26,514$0.46M0.0%+96.3%0.023%Search for SEC Filing on Google Icon
11/13/2025Invesco Ltd.409,420$7.07M0.0%+62.7%0.353%Search for SEC Filing on Google Icon
11/13/2025Sei Investments Co.34,751$0.60M0.0%+32.3%0.030%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets50,251$0.87M0.0%-88.2%0.043%Search for SEC Filing on Google Icon
11/13/2025Franklin Resources Inc.10,239$0.18M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/13/2025Swiss National Bank190,700$3.29M0.0%+1.8%0.165%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.11,308$0.20M0.0%+747.0%0.010%Search for SEC Filing on Google Icon
11/13/2025Pinnacle Associates Ltd.163,710$2.83M0.0%-3.3%0.141%Search for SEC Filing on Google Icon
11/13/2025Blair William & Co. IL20,160$0.35M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/12/2025Aptus Capital Advisors LLC71,481$1.23M0.0%-5.0%0.062%Search for SEC Filing on Google Icon
11/12/2025Orchard Capital Management LLC81,598$1.41M1.2%+3.0%0.070%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC488,226$8.43M0.0%-5.8%0.422%Search for SEC Filing on Google Icon
11/12/2025Amova Asset Management Americas Inc.2,354,856$40.62M0.4%-11.8%2.033%Search for SEC Filing on Google Icon
11/12/2025ARK Investment Management LLC11,919,178$205.84M1.2%-8.4%10.290%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP1,757,294$30.35M0.0%-5.8%1.517%Search for SEC Filing on Google Icon
11/12/2025Contrarius Group Holdings Ltd5,889,936$101.72M4.6%+279.4%5.085%Search for SEC Filing on Google Icon
11/12/2025Creekmur Asset Management LLC38,677$0.67M0.1%-34.0%0.033%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC183,091$3.16M0.0%+42.2%0.158%Search for SEC Filing on Google Icon
11/12/2025Erste Asset Management GmbH23,100$0.39M0.0%-72.9%0.020%Search for SEC Filing on Google Icon
11/12/2025R Squared Ltd10,782$0.19M0.1%N/A0.009%Search for SEC Filing on Google Icon
11/12/2025Interchange Capital Partners LLC11,695$0.20M0.0%+9.7%0.010%Search for SEC Filing on Google Icon
11/12/2025IvyRock Asset Management HK Ltd14,330$0.25M0.1%N/A0.012%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC44,587$0.77M0.0%-22.2%0.038%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Intellia Therapeutics logo
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Read More on Intellia Therapeutics

Today's Range

Now: $12.49
Low: $11.76
High: $12.50

50 Day Range

MA: $10.90
Low: $8.10
High: $15.90

52 Week Range

Now: $12.49
Low: $5.90
High: $28.25

Volume

4,004,641 shs

Average Volume

6,442,351 shs

Market Capitalization

$1.45 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.1

Who are the company insiders with the largest holdings of Intellia Therapeutics?

Intellia Therapeutics' top insider investors include:
  1. John M Leonard (CEO)
  2. William J Chase (Director)
  3. Edward J Dulac III (EVP)
  4. Birgit C Schultes (EVP)
  5. James Basta (EVP)
  6. Eliana Clark (EVP)
  7. Michael P Dube (CAO)
  8. Jesse Goodman (Director)
  9. Muna Bhanji (Director)
Learn More about top insider investors at Intellia Therapeutics.

Who are the major institutional investors of Intellia Therapeutics?

Intellia Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 11.23%
  2. Geode Capital Management LLC — 2.33%
  3. Sumitomo Mitsui Trust Group Inc. — 1.89%
  4. GSA Capital Partners LLP — 0.20%
  5. Hennion & Walsh Asset Management Inc. — 0.14%
  6. Pinnacle Associates Ltd. — 0.13%
Learn More about top institutional investors of Intellia Therapeutics stock.

Which institutional investors are selling Intellia Therapeutics stock?

Within the previous quarter, NTLA stock was sold by these institutional investors:
  1. Sumitomo Mitsui Trust Group Inc.
  2. SG Americas Securities LLC
  3. Generali Investments Towarzystwo Funduszy Inwestycyjnych
  4. China Universal Asset Management Co. Ltd.
  5. Universal Beteiligungs und Servicegesellschaft mbH
  6. Pinnacle Associates Ltd.
  7. Lewis Asset Management LLC
  8. LMG Wealth Partners LLC
In the previous year, company insiders that have sold Intellia Therapeutics company stock include:
  1. John M Leonard (CEO)
  2. William J Chase (Director)
  3. Edward J Dulac III (EVP)
  4. Birgit C Schultes (EVP)
  5. James Basta (EVP)
  6. Eliana Clark (EVP)
  7. Michael P Dube (CAO)
  8. Jesse Goodman (Director)
Learn More investors selling Intellia Therapeutics stock.

Which institutional investors are buying Intellia Therapeutics stock?

Within the last quarter, NTLA stock was purchased by institutional investors including:
  1. Vanguard Group Inc.
  2. GSA Capital Partners LLP
  3. Geode Capital Management LLC
  4. Canal Insurance CO
  5. Wesbanco Bank Inc.
  6. Leonteq Securities AG
  7. IMC Chicago LLC
  8. Profund Advisors LLC